Pneumonia is one of the most important health problems facing the American cattle industry, with annual losses from respiratory disease estimated to be in excess of $500 million (26) . Many agents contribute to this loss, but the role of Haemophilus somnus is only beginning to be recognized (40) . In addition to causing bovine respiratory disease (2, 17) , H. somnus is associated with a wide variety of other diseases in cattle, including thromboembolic meningoencephalitis (17, 33) and reproductive failure (7, 17) . Clinically normal cattle may also harbor H. somnus in the nasal cavity (12, 17) or genital tract (11, 17) or both; however, the relationship between these carrier states and disease has not been established.
Killed H. somnus vaccines are commercially available, but there is minimal evidence for the efficacy of such vaccines in the prevention of pneumonia (15, 25) . Therefore, development of a more efficacious vaccine is an important research priority. The low level of protection induced by many killed bacterial vaccines is thought to be due to antigenic competition, often resulting in minimal immunity to the most protective antigens (4) . Therefore, it is important to know which antigens stimulate protective immunity (27) and to immunize with purified protective immunogens. If humoral immunity is protective, then antigens recognized during the course of infection are potentially protective immunogens. It is probable that humoral immunity is likely to be protective in H. somnus-induced pneumonia for sev-eral reasons: (i) serum exudation is marked in acute H. somnus pneumonia (14a) , and thus serum antibody would be present in infected tissues; (ii) immunoglobulin concentrations in nasal secretions and serum are correlated with the susceptibility of young calves to pneumonia (10) ; and, (iii) antibody is protective in other pneumonias, such as Pseudomonas aeruginosa pneumonia in guinea pigs (28) . Therefore, we conducted experiments to determine whether preincubation of bacteria with convalescent serum would passively protect calves against H. somnus pneumonia and to define the antigenic specificity of protective serum.
MATERIALS AND METHODS
Bacteria. H. somnus 2336 passaged once in a calf was used throughout the study. This strain was isolated at the Washington Animal Disease Diagnostic Laboratory from the lungs of a vealer calf during an outbreak of H. somnus pneumonia.
Isolates from the primary culture were stored at -70°C in 40% phosphate-buffered saline-60% glycerol.
Animals. Holstein bull calves were purchased from dairies in which H. somnus inocutated into a caudal lung lobe with a polyethylene nasotracheal tube (diameter, 6.5 mm; Bev-a-line tubing; Cole Parmer Instrument Co., Chicago, Ill.). Bronchoalveolar lavage was performed before inoculation and at weekly intervals after inoculation. Lavage fluid was retrieved immediately after instillation of 60 ml of sterile, lactated Ringer solution (Travenol Laboratories, Inc., Deerfield, Ill.). After the fluid was centrifuged at 10,000 x g for 20 min, the pellet was resuspended in 2 ml of supernatant, and bacterial plate counts were done in duplicate by the drop method (9) . Serum was collected before inoculation and at weekly intervals after inoculation and was stored in small aliquots at -20°C. Calves were necropsied 6 weeks postinoculation.
Enzyme-linked immunosorbent assay. Antibody titers were determined as described previously (39 Gaithersburg, Md.) . Reactions were developed with hydrogen peroxide in 5-aminosalicylic acid, and plates were read in the dual-wavelength mode of an enzyme-linked immunosorbent assay reader (Dynatech Laboratories, Inc., Alexandria, Va.). Titers for each serum sample were derived by fitting regression lines of optical density against serum dilution, and from these lines, the reciprocal of the serum dilution at an optical density of 0.2 was determined. Variation between plates was controlled by including a hightitered positive control serum on each plate and correcting the sample endpoint as follows: corrected sample endpoint = (sample endpoint for plate X x mean high-titered serum endpoint of all samples)/high-titered serum endpoint for plate X.
Passive protection experiment. Pooled convalescent serum samples (collected 6 weeks after infection) or preimmune serum was heated for 30 min at 56°C. Bacteria were prepared as described previously except that 10% fetal calf serum (HyClone Laboratories, Logan, Utah) was substituted for bovine blood in Columbia blood agar plates. Equal volumes of a 1:2 dilution of serum in sterile normal saline and an H. somnus suspension (107 CFU/ml) were incubated at room temperature for 5 min before intrabronchial inoculation of 2 ml of each reaction mixture (107 CFU of H. somnus; 1:4 dilution of serumn). Bacterial counts were done before and after incubation to determine whether agglutination had occurred. Serum H. somnus enzyme-linked immunosorbent assay titers for recipient calves before inoculation were less than 100 for IgG2 and IgM, and mean IgGl titers were 234 + 151. Four male Holstein calves (6, 8, 9 , and 9 weeks old) were sedated with xylazine (Rompun; Haver-Lockhart, Shawnee, Kans.) and were inoculated by using a flexible fiber-optic bronchoscope (diameter, 6 mm; Machida, Norwood, N.J.). Bacteria incubated with convalescent serum were inoculated into one caudal lung, and bacteria incubated with preimmune serumn were inoculated into the contralateral lung. The sides were reversed in each successive calf. A vehicle control of 2 ml of a 1:4 dilution of normal bovine serum in sterile saline was inoculated into the anterior bronchus of each calf.
Twenty-four hours postinoculation, the calves were heparinized (1,000 IU/kg; intravenous heparin sodium [IlkinsSinn, Inc., Cherry Hill, N.J.] injection) and then killed with an intravenous overdose of sodium pentobarbitone (Veterinary Laboratories, Inc., Lenexa, Kans.). Bronchoalveolar lavage of left and right caudal lung lobes was done before fixation of the lungs, as described above for preparation of convalescent serum except that ohly 20 ml of lactated Ringer solution was used. The lungs were perfused with saline before swabs of caudal lungs were taken for bacteriologic and virologic culture and before being fixed by vascular perfusion with 4% formaldehyde-1% glutaraldehyde, as described previously (14a). The fixed lungs were sectioned serially every 3 mm starting at the caudal extremity of each caudal lung. The lung slices were designated 0, 1, 2, 3, etc., starting with the caudalmost lung slice. After postfixation overnight in 4% formaldehyde-1% glutaraldehyde, the lesions were delineated grossly and areas of pneumonic lung were determined by using a computerized image analysis system (Bioquant II; R and M Biometrics, Nashville, Tenn.) as described previously (13, 14a) . For each calf, the volumes of pneumonic lung in each lung slice (0, 1, 2, 3, etc.) from the left and right sides were compared by the paired t test (one tailed). In addition, the paired t test (one tailed) was used to compare the total volumes of pneumonic lung for each treatment for all four calves.
Slices of all grades of gross lesions were embedded in paraffin, sectioned at 5 ,Lm, mounted on glass slides, and stained with hematoxylin and eosin, on selected occasions, sections were stained by the method of Gram, as modified by Brown and Hopps (23) .
Isolation of bacterial outer membrane-enriched fractions. After 18 h of growth on Columbia blood agar plates, the first subculture of H. somnus was inoculated into brain heart infusion broth (Difco) containing 1 mg of Trizma base per ml and 10 ,ug of thianmine monophosphate (Sigma Chemical Co., St. Louis, Mo.) per ml and grown overnight at 37°C in a shaking water bath to a density of 5 x 108 CFU/ml. The bacteria were washed twice in 0.05 M Tris hydrochloride (pH 7.8) at 4°C, suspended in the same buffer containing 2 mM MgCl2, and sonicated (Biosonik IV; VWR Scientific, San Francisco, Calif.) for 3 min in 15-s bursts (80 W) on ice. Cellular debris was removed by centrifugation at 10,000 x g for 15 min at 4°C. The supernatant was centrifuged at 230,000 x g for 70 min. The pellet was suspended in 10 niM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer at pH 7.4 and extracted with an equal volume of 2% N-lauroylsarcosine (sarcosyl; Sigma) (3) in 10 mM HEPES for 20 min at room temperature. After centrifugation at 175,000 x g for 110 min, the insoluble pellet was resuspended in 10 mM HEPES at pH 7.4 SDS-polyacrylamide gel electrophoresis. For sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, outer membrane-enriched fractions (about 1 mg of protein per ml) or whole bacteria (3 x 109/ml) were solubilized by boiling for 5 min in SDS-gel sample buffer (21) , and approximately 5 jig of outer membrane-enriched fraction or 108 bacteria per lane were resolved in 7.5 to 17.5% (wt/vol) polyacrylamide gradient slab gels run under reducing conditions with the buffer system of Laemmli (21) A similar discontinuous gel system (21) with a 15% polyacrylamide running gel incorporating 3 M urea was used to resolve LPS. Purified LPS from Escherichia coli O111:B4 and E. coli J5 (Sigma) were used as controls. Samples containing 1 to 10 jig of LPS were prepared as described previously (18) . LPS was visualized in gels by silver staining (37) or electroblotted onto nitrocellulose.
Western blots. After SDS-polyacrylamide gel electrophoresis, the gel was equilibrated for 30 min in transfer buffer (0.025 M Tris base, 0.192 M glycine, 20% methanol), and outer membrane-enriched fraction or LPS was electrotransferred to nitrocellulose paper (pore size, 0.45 ,um; Bio-Rad) (36) in a Trans-Blot chamber (Bio-Rad) overnight at 0.1 A (25 V) followed by 70 V for 1 h. Successful transfer of proteins was verified by amido black staining (0.1% in 25% isopropyl acetic acid) of a nitrocellulose strip containing the blotted protein standards. The rest of the nitrocellulose was rinsed 12 ,000 10 Affinity purification of antibodies directed against the bacterial surface. Bacteria were prepared as described above for outer membrane preparations except that broths were harvested during the log phase after 5 h of incubation (approximately 108 CFU/ml). Pellets of live bacteria (approximately 2.5 x 1010 CFU) were washed twice in sterile saline and suspended in 2 ml of a 1:8 dilution of heat-inactivated (56°C for 30 min) preimmune or convalescent bovine serum for 1 h at room temperature with gentle agitation. After centrifugation at 10,000 x g for 15 min at 4°C, the pellet was washed three times to remove any unattached antibody. The bacterial pellet was suspended in 2 ml of cold (4°C) glycine hydrochloride (1.5 ml of 0.2 M glycine, 0.5 ml of 0.2 M HCl, 58.6 mg of NaCl [pH 2.2]) and centrifuged immediately at 10,000 x g for 15 min at 4°C. The supernatant was recovered and added to 30 RI of 1.5 M Tris hydrochloride (pH 7.4) before dialysis in phosphate-buffered saline at 4°C. The dialyzed supematant is referred to as the preimmune or convalescent eluate and was diluted 1:30 with TBS-Tween (pH 7.5) for use in immunoblots.
RESULTS
Calves with chronic experimental H. somnus pneumonia. Calves with chronic experimental pneumonia were mildly depressed for a few days after inoculation, coughed occasionally, and had a mild febrile response. Titers of antibody to H. somnus in serum in the two chronically infected calves were almost always within one doubling dilution of each other. IgM titers were highest during the first 2 weeks, whereas IgGl and IgG2 titers increased more gradually, stabilizing at high antibody concentrations by weeks 2 and 3 (Fig. 2) . For each calf, the lesion volume in each lung slice of protected lung was significantly different (P < 0.0005) from the lesion volume on the unprotected side ( Table 2 ). The difference in the total volumes of pneumonic lung for each treatment for all four calves was also statistically significant (P < 0.05). Occasional, small areas of firm crimson tissue were present in the right cranial lobes of two of the four calves at the site of deposition of the diluent control. H. somnus was recovered from swabs of the anterior bronchi in the calves with mild anterior lesions but not from the other two calves. Histologically, typical lesions in protected lungs contained mild, focal exudation of neutrophils into alveoli and bronchioles, as opposed to marked, well-demarcated, fibrinous bronchopneumonia in unprotected lungs (Fig. 3) . The latter were characterized by suppurative necrotizing bronchiolitis, vasculitis, lymphatic dilation, lobular necrosis, hemorrhage, and degeneration of alveolar macrophages. Gram-negative bacteria with the morphology of H. somnus were present in alveoli of severely affected areas of unprotected lung in all calves.
The only pathogenic bacterium isolated from the lungs of all four calves was H. somnus. Since it is not possible to quantitate bacterial numbers in pulmonary lesions and concurrently perform morphometric analysis, we estimated bacterial numbers in bronchoalveolar lavage samples taken at necropsy from protected and uprotected sides of the lungs. Significantly greater numbers of H. somnus were recovered from postmortem lavage of unprotected lungs than from lavage of protected lungs (P < 0.05) (Table 3) . Viruses, mycoplasmas, and bacterial pathogens other than H. somnus were not recovered from the lungs of any calf in this acute experiment. Inoculum was incubated with preimmune or convalescent serum. There was a statistically significant difference between the preimmune and convalescent sera when volumes of pneumonic lung were compared for each calf at each level of the lungs; P < 0.0005 (one-tailed, paired t test). There was also a statistically significant difference between the preimmune and convalescent sera when total volumes of pneumonic lung were compared for each treatment for all four calves; P < 0.05 (one-tailed, paired t test). Electron microscopy. Sarcosyl-insoluble pellets were composed of abundant vesicles and ribbons of bilaminar membranes characteristic of the outer membranes of gramnegative bacteria (Fig. 4) .
Western blots of bacterial lysates and outer membraneenriched fractions. Immunoblots of whole bacterial lysates had essentially no reactivity with preimmune serum, but with convalescent serum there was intense reactivity at 78 and 40 kDa and weaker reactivity at 60, 38, 34, 31, 18, and 15 kDa (Fig. 5) . More than 40 nonimmunoreactive protein bands were visualized after counterstaining of replicate blots with amido black (Fig. 5) . Interestingly, the 41-kDa predominant outer membrane protein was not immunoreactive (Fig. 6) .
With immunoblots of outer membrane-enriched fractions, no reactivity was detected with preimmune serum at 1:1,500 dilution, but with convalescent serum there was intense reactivity at 78 and 40 kDa and weaker reactivity at 60, 34, 31, 29, 18, and 15 kDa (Fig. 6) . If blots of outer membraneenriched fractions were developed for a longer time, faint bands were recognized by convalescent serum at 38 and 27 kDa (data not shown). The reactivity observed with preimmune and convalescent eluates was almost identical to that observed with the corresponding homologous antisera ( a There was a significant difference between the protected and unprotected lobes for each calf; P < 0.05 (one-tailed, paired t test).
b Inoculum incubated with preimmune serum. c Inoculum incubated with convalescent serum.
6). Convalescent sera and eluates from both calves produced essentially identical results in Western blots (data for one calf are shown in Fig. 6 ). LPS electrophoretic profile and Western blotting. In SDSpolyacrylamide gels H. somnus LPS (1 to 2 ,ug) contained five closely spaced bands of slightly higher molecular weight than that of LPS from the rough mutant E. coli J5 and lacked the extensive heterogeneity of LPS from E. coli O111:B4 (Fig. 7) . In Western blots (2 jig of LPS per well), convalescent serum reacted intensely with two bands at serum dilutions for which no reactivity was observed with preimmune serum (Fig. 6 ).
DISCUSSION
The initial objective of this study was to determine whether convalescent serum protects calves against H. somnus pneumonia. Serum samples used in this study were collected from calves convalescing from H. somnus pneumonia, as indicated by the presence of mild, clinical respiratory disease in the inoculated calves, the ability to isolate H. somnus from bronchoalveolar lavage fluid of infected calves for 5 weeks after inoculation, the marked elevations (24) . In the last study, antisera prepared against purified E. coli J5 LPS gave protection just as potent as that observed with antisera prepared against whole boiled E. coli. More recently, human monoclonal IgM antibodies reactive against a wide range of bacterial LPSs provided protection against a range of gramnegative bacteremias in mice (34) . Antibodies specific for homologous LPSs protect against P. aeruginosa infection in rats (30) and guinea pigs (28), S. typhimurium infection in mice (22) , and E. coli Kl infection in neonatal rats (29) . Antibodies to outer membrane proteins also protect against many experimental infections including S. typhimurium (20) , H. influenzae (19) , and Neisseria meningitidis (14) . Determination of the specificity of the protective serum would permit identification of antigens potentially useful in prophylaxis. Antigens involved in endothelial or macrophage toxicity or both might also be identified. Relatively few immunodominant antigens were recognized by protective convalescent serum at a dilution of 1:1,500, as shown in VOL. 55, 1987 on October 19, 2017 by guest http://iai.asm.org/
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Western blots against whole bacteria. The predominant serum antibody response was directed to outer membrane antigens of H. somnus, since the reactivity for whole bacteria and outer membrane-enriched fractions of H. somnus was essentially the same. By adsorbing convalescent serum with live H. somnus and eluting the adsorbed antibody, we showed that the predominant antibody reactivity in protective convalescent serum was directed to antigens exposed and accessible on the bacterial surface. This provides added reason to suspect that these antigens may be important in protection, since the bacterial surface is the primary target of host effector functions. In addition, the antibodies in convalescent serum eluted from live H. somnus are likely to react predominantly with epitopes that are conserved after solubilization of bacterial antigens, since convalescent serum and eluates reacted almost identically in Western blots of H. somnus outer membrane-enriched fractions. The intense reactivity of convalescent serum in Western blots against purified H. somnus LPS confirmed that there is a strong response to LPS of the bacterial outer membrane in experimental, chronic H. somnus pneumonia.
In summary, convalescent sera obtained from calves with experimental H. somnus pneumonia protected calves against acute H. somnus pneumonia. The specificity of this protection was directed primarily against surface-accessible antigens of the bacterial outer membrane. Intense reactivity was detected against LPS as well as 78-and 40-kDa outer membrane antigens, with weaker reactions against 60-, 34-, 31-, 29-, 18-, and 15-kDa antigens. It is likely that one or more of these antigens may be useful prophylactically. These antigens may also be useful in serologic diagnosis of H. somnus infection, since convalescent calves had high IgGl and IgG2 titers to H. somnus over several weeks.
